CeriBell Intangible Assets from 2010 to 2026
| CBLL Stock | 19.77 0.80 3.89% |
Intangible Assets | First Reported 2010-12-31 | Previous Quarter 419.4 K | Current Value 372.8 K | Quarterly Volatility 24.6 K |
Check CeriBell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CeriBell's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 911.2 K or Interest Expense of 2.1 M, as well as many indicators such as Price To Sales Ratio of 5.16, Dividend Yield of 0.0 or PTB Ratio of 1.53. CeriBell financial statements analysis is a perfect complement when working with CeriBell Valuation or Volatility modules.
CeriBell | Intangible Assets | Build AI portfolio with CeriBell Stock |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of CeriBell Correlation against competitors. For more information on how to buy CeriBell Stock please use our How to buy in CeriBell Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell. Projected growth potential of CeriBell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CeriBell assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.67) | Revenue Per Share | Quarterly Revenue Growth 0.314 | Return On Assets | Return On Equity |
The market value of CeriBell is measured differently than its book value, which is the value of CeriBell that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell's value that differs from its market value or its book value, called intrinsic value, which is CeriBell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell's market value can be influenced by many factors that don't directly affect CeriBell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CeriBell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CeriBell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CeriBell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.